Lupin Allots 36,752 Equity Shares Under ESOP, Paid-Up Capital Rises to ₹91,44,31,726

1 min read     Updated on 04 May 2026, 12:24 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Lupin Limited, on May 4, 2026, allotted 36,752 fully paid-up equity shares of ₹2/- each under its Employee Stock Option plans, following the exercise of vested options by employees and subsidiary staff. The allotment was approved by the company's Operations and Finance Committee at its meeting on the same date. As a result, the company's issued and paid-up share capital has increased to ₹91,44,31,726, comprising 45,72,15,863 equity shares of ₹2/- each. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

powered bylight_fuzz_icon
39423279

*this image is generated using AI for illustrative purposes only.

Lupin Limited allotted 36,752 fully paid-up equity shares of ₹2/- each on May 4, 2026, pursuant to the exercise of vested options granted to employees of the company and its subsidiaries. The allotment was approved by the Operations and Finance Committee at its meeting held on May 4, 2026, and was disclosed under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

ESOP Allotment Details

The shares were allotted under the company's Stock Option plans, following the exercising of vested options by eligible employees. The key parameters of this allotment are summarised below:

Parameter: Details
Allotment Date: May 4, 2026
Number of Shares Allotted: 36,752
Face Value per Share: ₹2/-
Allotting Authority: Operations and Finance Committee
Scheme: Stock Option Plans (ESOP)
Beneficiaries: Employees of the company and its subsidiaries

Impact on Share Capital

Following the allotment, the issued and paid-up share capital of Lupin Limited has been revised upward. The updated capital structure is as follows:

Capital Parameter: Post-Allotment Figure
Total Paid-Up Share Capital: ₹91,44,31,726
Total Number of Equity Shares: 45,72,15,863
Face Value per Share: ₹2/-

The disclosure was made by Amit Kumar Gupta, Company Secretary and Compliance Officer, on behalf of Lupin Limited, in accordance with applicable listing regulations.

Historical Stock Returns for Lupin

1 Day5 Days1 Month6 Months1 Year5 Years
-0.23%+0.81%+3.02%+17.34%+12.37%+121.49%

How might the gradual dilution from recurring ESOP allotments impact Lupin's earnings per share trajectory over the next 2-3 years?

What does the frequency and scale of Lupin's ESOP exercises indicate about employee retention and talent competition in the Indian pharmaceutical sector?

Could increased employee ownership through ESOPs influence Lupin's strategic decision-making or corporate governance practices going forward?

Lupin Limited Announces Q4 FY26 Earnings Call Scheduled for May 8, 2026

1 min read     Updated on 25 Apr 2026, 11:01 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Lupin Limited has officially announced its Q4 FY26 earnings call scheduled for May 8, 2026 at 16:00 hrs IST via Zoom platform. The announcement was made in compliance with SEBI Listing Regulations, with proper notifications sent to NSE and BSE exchanges, and includes comprehensive stakeholder access arrangements.

powered bylight_fuzz_icon
38527480

*this image is generated using AI for illustrative purposes only.

Lupin Limited has officially announced its earnings call for the fourth quarter of fiscal year 2026, demonstrating its commitment to transparent stakeholder communication and regulatory compliance.

Earnings Call Schedule

The pharmaceutical company has scheduled its Q4 FY26 earnings call with specific timing and platform details to ensure broad stakeholder participation.

Parameter: Details
Date: May 8, 2026 (Friday)
Time: 16:00 hrs IST
Platform: Zoom Call
Registration: Required in advance
Recommended Join Time: 15:55 hrs IST

Regulatory Compliance

The earnings call announcement was made in strict adherence to Indian securities regulations. Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations, the company has formally notified both major Indian stock exchanges about this quarterly disclosure event.

The notification was digitally signed by Amit Kumar Gupta, Company Secretary & Compliance Officer (ACS-15754), ensuring proper authorization and documentation of the regulatory filing. The official communication was filed on April 23, 2026.

Stakeholder Access

Lupin has provided multiple access methods for stakeholders to participate in the earnings call:

  • Digital Registration: Online registration link provided for Zoom access
  • QR Code Access: Quick response code available for mobile device registration
  • Advance Registration: Participants advised to register before the scheduled time
  • Early Join Recommendation: Stakeholders encouraged to join by 15:55 hrs IST

Exchange Notifications

The company has formally communicated the earnings call schedule to both primary Indian stock exchanges, maintaining transparency in its disclosure obligations.

Exchange: Details
NSE Symbol: LUPIN
BSE Scrip Code: 500257 (Equity)
Filing Date: April 23, 2026
Regulation: SEBI Listing Regulations 2015

This scheduled earnings call represents Lupin's ongoing commitment to maintaining regular communication with investors, analysts, and other stakeholders regarding its quarterly financial performance and business developments.

Historical Stock Returns for Lupin

1 Day5 Days1 Month6 Months1 Year5 Years
-0.23%+0.81%+3.02%+17.34%+12.37%+121.49%

What key performance metrics and growth initiatives will investors likely focus on during Lupin's Q4 FY26 earnings call?

How might Lupin's Q4 results influence its stock performance and analyst ratings in the upcoming quarter?

What regulatory or pipeline developments could Lupin announce that would significantly impact its future market position?

More News on Lupin

1 Year Returns:+12.37%